Rotella Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Rotella Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,514	Closed	-$134K	–	379
2015 Q4	$134K	Buy	+11,514	New	+$146K	0.12%	274
2015 Q3	–	Sell	-17,690	Closed	-$167K	–	769
2015 Q2	$167K	Buy	17,690 +2,700	+18%	+$25K	0.14%	200
2015 Q1	$133K	Buy	14,990 +2,511	+20%	+$25.4K	0.11%	315
2014 Q4	$125K	Sell	12,479 -3,800	-23%	-$32.6K	0.11%	211
2014 Q3	$109K	Sell	16,279 -6,621	-29%	-$46.4K	0.11%	159
2014 Q2	$164K	Buy	+22,900	New	+$182K	0.14%	145

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rotella Capital Management's BEAT Position: Q1 2016 in Review

Rotella Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2016, closing a stake of 11,514 shares — an estimated $134K sold.

Rotella Capital Management first reported a position in BEAT in Q2 2014 and held it in 6 quarters. The position peaked at $167K in Q2 2015. 112 funds tracked by Wall St. Rank hold BEAT as of Q1 2016.

Rotella Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2016 after selling out during the quarter.
Rotella Capital Management sold 11,514 BioTelemetry, Inc. shares in Q1 2016, an estimated $134K.
Rotella Capital Management first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 6 quarters.
Rotella Capital Management's BioTelemetry, Inc. position peaked at $167K in Q2 2015.
112 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.